Novel in-situ emulgel of acetazolamide for ocular drug delivery

8Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

In this investigation, a novel in-situ emulgel of acetazolamide was developed and evaluated. The gel was prepared using corn oil, pectin, and GellanGum at different concentrations of 10%–50% (w/w) and added to the homogenizer tube followed by the addition of the emulsifier (Tween 80 and span 80 in the ratio of 1:1) at 0.2% (w/w). The pH of all five formulations was between 5.58 and 5.75. The Fourier-transform infrared spectroscopy (FTIR) spectrum of all the formulations showed broadband in between the wavenumber range of 3,700 cm−1 and 2,980 cm−1. The FTIR spectrum of all the formulations showed broadband in between the wavenumber range of 3,700 cm−1 and 2,980 cm−1. The drug content in the samples was determined by a spectrophotometer at 267 nm The drug release mechanism may be Fickian transport (0.45 ≤ n), anomalous (non-Fickian) transport (0.45 ≤ n < 0.89), and/or super case-II transport (n > 0.89). The n values of all formulations were greater than 0.45. The in-vivo corneal tolerance experimentation of the prepared formulation eyes was assessed for 72 hours and found to be biocompatible based on visual inspection

Cite

CITATION STYLE

APA

Ali, F., Habibullah, S., Mohanty, B., Behera, A., Giri, Y., & Nayak, B. S. (2023). Novel in-situ emulgel of acetazolamide for ocular drug delivery. Journal of Applied Pharmaceutical Science, 13(4), 127–135. https://doi.org/10.7324/JAPS.2023.53382

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free